Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with JAK-inhibitors compared to bDMARDs: data from an international collaboration of registries (the "JAK-pot" study)

R Aymon, D Mongin, SA Bergstra, D Choquette, C Codreanu, RL Cordtz, D De Cock, L Dreyer, O Elkayam, D Huschek, KL Hyrich, F Iannone, N Inanc, L Kearsley-Fleet, TK Kvien, BF Leeb, G Lukina, D Nordström, F Onen, K PavelkaM Pombo-Suarez, S Provan, AM Rodrigues, Z Rotar, A Strangfeld, P Verschueren, J Zavada, D Courvoisier, A Finckh, K Lauper

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)2S-2S
Number of pages1
JournalSwiss medical weekly
Volume153
Publication statusPublished - 28 Aug 2023

Cite this